Therapeutic agents based on proteins or nipples, or bicellular or bicellular hemoglobin secondary units, are also effective in the treatment of cancer. The rest of recombinant hemoglobin or papilla or bicellular hemoglobin or bicellular hemoglobin or bicellular hemoglobin, or the daughter cells of bicellular hemoglobin, can be transferred to cancer cells, and the rest of the treatment (i.e. active agents / therapeutic drugs) can effectively kill cancer cells. Reproducing proteins or papillary or papillary protein therapeutics or the auxiliary devices used by them can be used to treat various cancers, such as pancreatic cancer, leukemia, head cancer and cervical cancer, rectal cancer, lung cancer, breast cancer.Liver cancer, nasal cancer, esophageal cancer, prostate cancer, gastric cancer and brain cancer. This component can be used alone or in combination with another (s) therapeutic agent, such as chemotherapy agent, radiotherapy agent, protein anticancer drug, which can play a synergistic role in cancer treatment by inhibiting metastasis and / or reducing recurrence. Requirement 1: re matched hemoglobin, whether or not there is plasma, including teapot, nipple,And / or recombinant hemoglobin subunits are used as carriers and oxygen supplies to replace natural or native hemoglobin molecules isolated and / or purified from animal or human sources. Second requirement The recombinant hemoglobin in the first requirement, wherein the subunit of the recombinant hemoglobin is a recombinant hemoglobin monomer, which is established and expressed according to the 141-146 amino acid sequence from homosexuals. Claim 9: a method of reconstituting hemoglobin molecules for claim 1, including the manufacture of an encrypted fusion gene for ferritin,Recombinant hemoglobin binary and / or subunit, insert fusion gene into vector, insert vector into host organism, and express protein, teapot, diode or subunit required in Item 1.El agente terapéutico basado en proteína o tetrámero o dí
